YD Bio Limited (YDES)
NASDAQ: YDES · Real-Time Price · USD
5.20
-0.26 (-4.76%)
At close: Apr 28, 2026, 4:00 PM EDT
5.10
-0.10 (-1.92%)
After-hours: Apr 28, 2026, 6:59 PM EDT
YD Bio Market Cap
YD Bio has a market cap or net worth of $365.66 million as of April 28, 2026. Its market cap has increased by 692.41% in one year.
Market Cap
365.66M
Enterprise Value
362.55M
1-Year Change
692.41%
Ranking
Category
Stock Price
$5.20
Market Cap Chart
Since December 23, 2020, YD Bio's market cap has increased from $148.36M to $365.66M, an increase of 146.48%. That is a compound annual growth rate of 18.37%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vanda Pharmaceuticals | 401.34M |
| Niagen Bioscience | 398.03M |
| Lineage Cell Therapeutics | 386.09M |
| Enanta Pharmaceuticals | 385.38M |
| Avalo Therapeutics | 385.22M |
| X4 Pharmaceuticals | 382.77M |
| Puma Biotechnology | 382.08M |
| Rocket Pharmaceuticals | 380.84M |